Skip to main content

Table 2 Median prices of anti-malarials being sold in the public, private and NGO sector

From: Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi

  Public sector Private sector NGO sector
  No. of anti-malarials Median price (range) US$ No. of anti-malarials Median price (range) US$ No. of anti-malarials Median price (range) US$
ASAQ 28 0.16 (0.16-0.16) 19 0.56 (0.16-2.82) 15 0.16 (0.08-2.42)
Quinine 53 0.59 (0.03-1.77) 73 1.09 (0.24-3.39) 25 1.19 (0.16-2.58)
   Quinine injection 19 0.24 (0.12-0.48) 25 0.36 (0.24-1.61) 9 0.32 (0.16-0.81)
   Quinine tablet 34 1.53 (0.03-1.77) 48 1.61 (0.32-3.39) 16 1.61 (0.51-2.58)
Non-policy anti-malarials 2 8.90 (0.32-11.29)a 19 8.55 (8.35-9.44) 0  
  1. ACT, artemisinin combination therapies; US$, United States Dollars
  2. Anti-malarials that were offered for free (n = 4; 1 ACT, 1 quinine injection, and 2 quinine tablets) were excluded from median price calculations.
  3. aMean was calculated since there were only two other anti-malarials available in the public sector. According to WHO-HAI methods, there should be at ≥4 medicines to calculate the median.